Chr. Hansen reports 13% revenue growth

11 Jul 2016

Chr. Hansen has reported strong organic revenue growth of 13% in the first nine months of 2015/16, with Food Cultures & Enzymes up 13%, Health & Nutrition up 2% and Natural Colors up 20%.

Chr. Hansen reports 13% revenue growth

Chr. Hansen has reported strong organic revenue growth of 13% in the first nine months of 2015/16, with Food Cultures & Enzymes up 13%, Health & Nutrition up 2% and Natural Colors up 20%. EBIT before special items increased by 18% to €189 million. In Q3, organic growth reached 12% and EBIT before special items increased by 11% to €71 million.

“We continued to grow our business during Q3, with Food Cultures & Enzymes and Natural Colors showing strong organic revenue growth,” said CEO Cees de Jong. “Both Food Cultures & Enzymes and Natural Colors also delivered encouraging improvements in profitability. We experienced modest growth in Health & Nutrition, as the animal health business was negatively impacted by commodity prices for milk and meat remaining at extraordinarily low levels. Despite the current pressure on the agricultural sector, the long-term growth prospects for our animal health business remain very positive.”

“During the past three months, we have made good progress with integrating NPC, launched a second product for plant health with good first sales, and, within the human microbiome area, successfully completed a clinical study showing a positive physiological effect of the bacteria tested. Based on the results achieved, we have moved to the next stage in our clinical development plan. Finally, it is very encouraging to see a strong performance by our bioprotective solutions for dairy and other food categories.”

The company said its outlook for 2015/16 is unchanged compared to the April announcement.